Italy
# |
Name |
Operating Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 615.90 M
|
Dec. 31, 2023 | USD 61.85 | 0.84% |
|
Italy |
|
2 |
USD 260.25 M
|
Dec. 31, 2023 | USD 107.00 | 0.25% |
|
Italy |
|
3 |
USD 250.69 M
|
Dec. 31, 2023 | USD 41.35 | 1.53% |
|
Italy |
|
4 |
USD 3.00 M
|
Dec. 31, 2023 | USD 7.70 | 1.62% |
|
Italy |
|
5 |
USD -1.69 M
|
Dec. 31, 2023 | USD 1.99 | -0.79% |
|
Italy |
|
6 |
USD -9.76 M
|
Dec. 31, 2023 | USD 19.14 | -0.29% |
|
Italy |
|
7 |
USD -12.84 M
|
Dec. 31, 2023 | USD 10.86 | 4.76% |
|
Italy |
|
8 |
USD -12.95 M
|
Dec. 31, 2023 | USD 3.52 | -12.00% |
|
Italy |
The Biotechnology company in Italy with the highest Operating Income is Recordati Industria Chimica e Farmaceutica S.p.A. (Milan Stock Exchange: REC.MI) at USD 615.90 M.
The Biotechnology company in Italy with the lowest Operating Income is Genenta Science S.p.A. (NasdaqCM: GNTA) at USD -12.95 M.
The top 10 Biotechnology companies in Italy by Operating Income are Recordati Industria Chimica e Farmaceutica S.p.A., DiaSorin S.p.A., SOL S.p.A., Franchetti S.p.A., Arterra Bioscience, Philogen S.p.A., Newron Pharmaceuticals S.p.A. and Genenta Science S.p.A..
The bottom 10 Biotechnology companies in Italy by Operating Income are Genenta Science S.p.A., Newron Pharmaceuticals S.p.A., Philogen S.p.A., Arterra Bioscience, Franchetti S.p.A., SOL S.p.A., DiaSorin S.p.A. and Recordati Industria Chimica e Farmaceutica S.p.A..